Prevalence and characteristics of the metabolically healthy obese phenotype in children and adolescents in a Mexican state.

Adolescentes Adolescents Children Cociente triglicéridos/HDL HOMA-IR Insulin resistance Metabolically Obese Normal-Weight Metabolically healthy obese Metabólicamente obeso con peso normal Niños Obeso metabólicamente sano Resistencia a la insulina Triglycerides/HDL ratio

Journal

Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 09 08 2019
revised: 17 03 2020
accepted: 25 03 2020
pubmed: 15 10 2020
medline: 15 10 2020
entrez: 14 10 2020
Statut: ppublish

Résumé

To determine the prevalence of the Metabolically Healthy Obesity (MHO), and Metabolically Obese Normal-Weight (MONW) phenotypes in a sample of children and adolescents. To evaluate which clinical and laboratory variables are related to the MONW and MHO phenotypes. A cross-sectional study was carried out in children and adolescents aged 6-18 years old, presumably healthy. Somatometry, glucose, insulin, triglycerides, HDL-cholesterol, LDL-cholesterol, HOMA-IR, triglycerides/HDL ratio, triglycerides and glucose index, and leptin/adiponectin, were determined. Data from 620 children and adolescents were included (50.65% were males); the median age was 11 years. The prevalence of the MONW phenotype was 22.85% (95%CI 16.85%-29.79%), and the MHO phenotype 27.61% (95%CI 22.60%-33.06%). The variables that significantly explained the possibility of presenting the MONW and MHO phenotype were triglycerides/HDL ratio, and product of triglycerides and glucose. Insulin and HOMA-IR were significantly associated with the MHO phenotype but not with the MONW phenotype. Prevalence of metabolically healthy obese phenotype is lower in the Mexican population compared to European studies; thus, future studies should determine if this difference relies upon genetic profile or lifestyle. The indices to assess the action of insulin based on lipids can help identify children and adolescents with the MHO and MONW phenotypes.

Identifiants

pubmed: 33051160
pii: S2530-0164(20)30160-9
doi: 10.1016/j.endinu.2020.03.015
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

625-635

Informations de copyright

Copyright © 2020. Publicado por Elsevier España, S.L.U.

Auteurs

María Luisa Pizano-Zárate (ML)

Departamento de Nutrición y Bioprogramación. Instituto Nacional de Perinatología, Secretaría de Salud; Unidad de Medicina Familiar N° 4, Delegación DF. Norte. Instituto Mexicano del Seguro Social.

Gabriel Horta-Baas (G)

Servicio de Reumatología, Hospital General Regional 1 Delegación Yucatán, Instituto Mexicano del Seguro Social.

Jorge A Nuñez-Hernández (JA)

Hospital General Regional 220 Toluca México, Delegación México Poniente Instituto Mexicano del Seguro Social.

Álvaro J Montiel-Jarquín (ÁJ)

Unidad Médica de Alta Especialidad de Puebla, México, Instituto Mexicano del Seguro Social.

Maricruz Tolentino-Dolores (M)

Departamento de Nutrición y Bioprogramación. Instituto Nacional de Perinatología, Secretaría de Salud.

María Hernández-Trejo (M)

Departamento de Nutrición y Bioprogramación. Instituto Nacional de Perinatología, Secretaría de Salud.

María Del Socorro Romero-Figueroa (MDS)

Universidad Anáhuac México, Centro de Investigación en Ciencias de la Salud Lomas Anáhuac 786, Huixquilucan, México. Electronic address: sromero61@hotmail.com.

Classifications MeSH